Skip to main content
. 2021 Jun 28;13(7):978. doi: 10.3390/pharmaceutics13070978

Table 5.

Pharmacokinetic (pK) parameters for Tramadol in brain and plasma following administration in the nanovesicular system (NVS), Nasal non-vesicular system (NV) and Oral preparation (PO).

pK Parameter Brain Plasma
NVS NV PO NVS NV PO
Tmax (min) 10.0 10.0 60.0 10.0 10.0 60.0
Cmax (µg/g)-for brain
(ng/mL)-for plasma
3.46 2.08 0.73 743.6 529.3 329.5
AUC0–240
(µg × min/g)-for brain
(ng × min/mL)-for plasma
361.80 195.90 168.43 17,577.0 8002.1 9660.7
F relative to PO 2.15 1.16 1.82 0.83